Published on
July 28, 2026
- 06:30 GMT
Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after ...
Good-to-excellent cosmetic outcomes 30 of 94 patients enrolled have now reached 24 months of follow-up High surgeon satisfaction sustained through study to date Improvements in patient-reported breast satisfaction and cancer worry were statistically …
Distribution channels:
